2019 Champions for Biotechnology Education

November 20, 2019 5:30 PM - 8:00 PM

UMass Club, 1 Beacon St., 32nd Fl, Boston, MA 02108

Add to Calendar 11/20/2019 5:30:00 PM 11/20/2019 8:00:00 PM 2019 Champions for Biotechnology Education

The Annual Champions for Biotechnology Education Awards Reception celebrates the outstanding advocacy for, and contributions to, life sciences education in the region. Each year, MassBioEd honors an individual, an organization, and an educator for their commitment to advancing biotechnology education.

Thank you to our Host Sponsors Alnylam Pharmaceuticals and Thermo Fisher Scientific.

Join us on Wednesday, November 20th to recognize the 2019 Champions for Biotechnology Education.

  • Individual Champion - John Maraganore, PhD; Chief Executive Officer, Alnylam Pharmaceuticals

  • Organization Champion - Thermo Fisher Scientific

  • Educator Champion,  Henri A. Termeer Teacher Award - Laurie Jackson-Grusby, Biology Teacher, Brockton High School

The event is reception-style, featuring a jazz trio, passed hors d'oeuvres, food stations, and a hosted bar. A reception will be followed by a short speaking program during which the three honorees will be awarded for their dedication to empowering students to enter careers in the life sciences.

Individual Admission - $150, Non-Profit/Academia - $125
Please contact megan.schulz@massbio.org to purchase a package of 10 event passes at a discount of $1,250 and receive recognition as a Table Host. 

For sponsorship opportunities, please view the 2019 Sponsorship Prospectus. 

All event proceeds support MassBioEd's mission to build a sustainable life sciences workforce in the region through educational programs that inspire and propel students, engage and excite teachers, and illuminate the pathway from classroom to careers.

 UMass Club, 1 Beacon St., 32nd Fl, Boston, MA 02108
Chief Executive Officer, Alnylam
Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. Prior to Alnylam, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc. As Senior Vice President, Strategic Product Development for Millennium, he was responsible for the company’s product franchises in oncology, and cardiovascular, inflammatory, and metabolic diseases. He was previously Vice President, Strategic Planning and M&A and, prior to that, he was General Manager of Millennium BioTherapeutics, Inc., a former subsidiary of Millennium. Before Millennium he served as Director of Molecular Biology and Director of Market and Business Development at Biogen, Inc. At Biogen, Dr. Maraganore invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection, formerly HIRULOGTM and currently marketed by The Medicines Company. Prior to Biogen, Dr. Maraganore was a scientist at ZymoGenetics, Inc., and the Upjohn Company. Dr. Maraganore received his MS and PhD in biochemistry and molecular biology at the University of Chicago. He is the Chair of the Board for Agios Pharmaceuticals. Dr. Maraganore is Chair of the Biotechnology Industry Organization (BIO) Board, and is a member of the BIO Executive Committee.

Brought to you by